1. Home
  2. FSBC vs AKBA Comparison

FSBC vs AKBA Comparison

Compare FSBC & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Star Bancorp

FSBC

Five Star Bancorp

HOLD

Current Price

$37.99

Market Cap

816.9M

Sector

Finance

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.42

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBC
AKBA
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
816.9M
729.1M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
FSBC
AKBA
Price
$37.99
$1.42
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$37.83
$6.25
AVG Volume (30 Days)
61.3K
3.0M
Earning Date
01-26-2026
03-12-2026
Dividend Yield
2.62%
N/A
EPS Growth
19.76
N/A
EPS
2.70
N/A
Revenue
$141,930,000.00
$225,071,000.00
Revenue This Year
$34.35
$52.38
Revenue Next Year
$17.79
$22.45
P/E Ratio
$14.18
N/A
Revenue Growth
25.41
32.49
52 Week Low
$22.22
$1.30
52 Week High
$40.31
$4.08

Technical Indicators

Market Signals
Indicator
FSBC
AKBA
Relative Strength Index (RSI) 56.26 42.94
Support Level $37.15 $1.35
Resistance Level $40.31 $1.41
Average True Range (ATR) 1.14 0.08
MACD 0.13 0.01
Stochastic Oscillator 50.72 43.40

Price Performance

Historical Comparison
FSBC
AKBA

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: